PLANKSTADT EXPERTS TAKING CARE
|
|
- Sharlene Pearson
- 6 years ago
- Views:
Transcription
1 CordenPharma PLANKSTADT EXPERTS TAKING CARE
2 Our History Start of Packaging activities (ICI Pharma) Start of Formulation activities (ICI Pharma) First Pre-approval Inspection by FDA Start of High Containment Manufacturing (AstraZeneca) Acquired by ICIG to become key plant of CordenPharma US
3 cordenpharma PLANKSTADT Strategic CMO Partner Highly Potent Solid Dosage Forms CordenPharma Plankstadt is your strategic partner in the development and manufacturing of highly potent solid dosage forms for global markets. Located near Heidelberg, Germany, our state-of-theart containment unit is physically segregated from other manufacturing areas. Full containment is achieved by means of technology, thereby avoiding the need for personal protective equipment. Our units are suitable for batch sizes between 80 and 150 kg, and are validated to handle compounds with an OEL of 1µg/m³/8h (G3b, SafeBridge Category 3). Products with an OEL <1µg/m³/8h (G4) can also be evaluated based on their specific characteristics. As your partner, we work with you to develop highly potent products - spanning all development phases from early feasibility to phase III clinical supplies for seamless transfer to commercial scale, all at the same site. Compliance Worldwide EMA FDA PMDA TGA Health Canada ANVISA
4
5
6
7 what we do Development & Scale-up Commercial Manufacturing CordenPharma Plankstadt is an internationally approved expert in formulation development, contract manufacturing and packaging of solid dosage forms, with specific experience in the development and manufacturing of oral dosage forms with highly potent compounds. As a full-service CMO for the global market we are committed to being fast, flexible, innovative and reliable. Our global expertise and familiarity with the specific quality standards needed for manufacturing in Europe, the USA, Brazil, and Japan make us your ideal partner for your new and existing products. Core Capabilities Technologies Direct compression Fluid bed granulation High shear granulation Tableting Tablet film-coating Encapsulation Focused Project Management CordenPharma Plankstadt s dedicated project managers with their project teams ensure consistent coordination, communication and alignment of progress throughout all phases of each project. A project manager is assigned at the start of the project to be your direct interface for all project activities from the kick-off meeting to successful implementation of your product. We take care to ensure that project objectives are defined and deliverables are detailed in a mutually-signed project specification document. Technical risks are identified, evaluated and mitigated on a continuous basis and the agreed mitigations are reported throughout the project. Updated project plans are generated and tracked vigorously to ensure that we will always deliver the highest quality to our customers within agreed-upon timelines. CordenPharma Plankstadt is your expert for highly potent solid dosage forms. We offer flexible, cost-effective pharmaceutical development and custom manufacturing services for global markets.
8
9
10
11 SERVICES With extensive experience in the development and optimization of formulations and processes for phase I - III clinical studies and commercial production, CordenPharma Plankstadt offers a comprehensive range of services in the area of pharmaceutical development comprising: Development and Scale-up of Solid Dosage Forms: Tablets Film-coated tablets (immediate release and modified release) Two-layer tablets Hard capsules Granules or powders for oral suspension/oral solution in single dosage units Analytical Development Services: Physical-chemical characterisation of drug substance Compatibility testing with excipients and investigation of drug-drug interactions QC release testing for clinical supplies Full support for stability studies according to ICH Q1A for all climate conditions Dissolution screening during formulation development, including testing in bio-relevant dissolution media (FaSSIF, FeSSIF) Development and justification of discriminating dissolution methods for IMPD/IND and MA/NDA Transfer, development, and validation of analytical methods for excipients, drug substances and drug products including microbiological methods (TAMC/TYMC/E.coli) acc. to Ph.Eur. for all solid dosage forms DEVELOPMENT Our team of experts takes care to develop your product from technical feasibility to phase III supplies. Your pharmaceutical development projects will benefit from our state-of-the-art technologies and extensive experience in formulation development and manufacturing of clinical supplies for highly potent pharmaceutical compounds with clearly defined OELs (e.g. hormones, hormone blockers, oncological compounds). All standard dosage forms can be developed in a scale of <100 g and scaled-up into pilot scale. Our development approach follows QbD principles from the start for all of our projects, while we tailor the extent of tools used for each development phase based on project needs and customer requirements. Thereby, we balance the benefits and costs of an integrated QbD approach to maximise the quality of our development projects, within the agreed budgets and time-frame. Feasibility testing and development of solid dosage forms are carried out in 3 separated cgmp suites, approved by global health authorities for manufacturing of clinical supplies. One of these cgmp suites is completely separated and validated for manufacturing of highly potent products with OELs <1µg/m 3 /8h, using personal protective equipment. DEVELOPMENT EQUIPMENT Direct Compression: lab blender for L and bin blender for 2 50 L High Shear Granulation: Diosna (bottom drive) granulator for kg and Henschel (bottom drive) granulator for 3-5 kg Fluid Bed Granulation: Glatt WSG (top spray) for 3-5 kg, Aeromatic Strea 1 (top spray and Wurster) for kg, Unilab 05 (tangential spray) for kg, Niro MP1 (top spray and bottom spray) for up to 7 kg Sieving: Erweka oscillating sieve, Quadro Comil centrifugal sieve, Alexanderwerk wet mill Tableting Press: Fette Exacta 1 (single punch) excenter-press and Korsch Pharmapress 230 rotary tablet press (with EURO B & D tooling) Tablet Film-coating (aqueous processes for immediate and modified release coating): Glatt GC 500 for up to 5 kg and Mini Coater Glatt for up to 2 kg tablets Multiparticulate Film-coating (aqueous processes for immediate and modified release coating): Unilab 05 (tangential spray) for kg, Niro MP1 (top spray and bottom spray) for up to 7 kg Hard Capsules: 3 Profill 3007 semi-automatic capsule fillers (for capsule size 000, 00, 0, 1, 3) and Bosch GKF 130 equipped with 100% weight check (for capsule size 00, 0, 1, 2, 3, 4, DBA, DBB)
12
13
14
15 COMMERCIAL PRODUCTION CordenPharma Plankstadt has well-known expertise and extensive capabilities in the manufacturing of solid oral dosage products, the production of highvolume non-potent tablets and capsules (a standard plant), and the manufacturing of pharmaceutical drug products with highly potent compounds (a containment plant). Our close cooperation between development and production ensures a smooth technology transfer during scale-up, customer transfer, process validation and routine manufacturing. Fully-Contained Plant Our fully-contained plant is validated to handle compounds with an OEB of 1µg/m³/8 hours, and is suitable for batch sizes between 80 and 150 kg, depending on product characteristics. Technologies include: Direct Compression: Kemutec Cone Mill CM220, Matcon Bin Blender 500 l Dry Granulation Fluid Bed Granulation: Glatt WSG 120 High Shear Granulation: Collette Gral 400 (top drive) High Speed Tableting: 2 IMA Comprima 3002 (specialised powder feeding implemented to minimise risk of segregation of powders) Tablet Film-coating: 2 Glatt GC 1250 Coater (for aqueous processes of immediate release and modified release coating) Plant for Highly Potent Products Our dedicated small plant for handling of highly potent pharmaceutical products (e.g. hormones, hormone blockers, oncological compounds) with clearly defined OEL levels has been validated down to 1µg/m³/8h, and is suitable for batch sizes between 40 and 150 kg, depending on product characteristics. In this plant organic solvents can be handled for high shear granulation and fluid bed granulation processes. Technologies include: Direct Compression: Engelsmann bin blender CM320 Dry Granulation High Shear Granulation: Diosna P250 (bottom drive) Fluid Bed Granulation: Aeromatic S5 (equipped with top spray granulation) Tableting: Fette 2090 (with EURO B & D toling) Tablet Film-coating: 48 " Accela Manesty Coater (for aqueous processes of immediate release and modified release coating) Non-potent Product Plant Our standard, non-potent product plant for the manufacturing of large-scale batches is suitable for batch sizes between 120 and 600 kg, depending on product characteristics. Technologies include: Direct Compression: Kemutec Cone Mill U20, Engelsmann bin blender CM1000 Dry Granulation High Shear Granulation: 2 Collette Gral 600 (top drive), 2 Kemutec Cone Mills U20 / U30, 2 Aeromatic T7 dryers Tableting on 6 rotary presses: - Fette 2090i Rotor EU1" Fette Fette 3002 for two-layer tablets - Kilian RX55 for two-layer tablets Tablet Film-coating: 60 " Accela Manesty Coater (for aqueous processes of immediate release and modified release coating) Hard Capsules: 2 Bosch GKF 1500 (equipped with IMA Precisa % weight check) for filling of combination capsules with tablets, granules and powders PACKAGING CordenPharma Plankstadt is an industry-recognised partner in supplying primary and secondary packaging of solid dosage forms. With our 9 validated blister lines, we have the capability for primary packaging of highly potent compounds up to OEB 3A and film-coated compounds up to OEB 4. Our plant is designed to support packaging operations from early-stage feasibility to commercial supplies, offering you a wide range of packaging solutions, packaging material and safety features that will secure your product quality. See our Packaging Brochure for more information.
16 CordenPharma Plankstadt Otto-Hahn-Strasse Plankstadt Germany Phone Fax
PACKAGING AT CORDENPHARMA
PACKAGING AT CORDENPHARMA PACKAGING AT CORDENPHARMA PLANKSTADT CordenPharma Plankstadt is an internationally approved expert in contract manufacturing and packaging of solid dosage forms and part of CordenPharma
More informationin full-service contract pharmaceutical development and manufacturing
in full-service contract pharmaceutical development and manufacturing THE Norwich Advantage Norwich is a recognized leader in full service contract pharmaceutical development and manufacturing. As a single-source
More informationFormulation Development & CTM Manufacturing Services
Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950 VxP Pharmaprovides an extensive range
More informationCORDENPHARMA BRUSSELS EXPERTS TAKING CARE
CORDENPHARMA BRUSSELS EXPERTS TAKING CARE Our History 1987: Peptisyntha founded by Solvay 1996: First pre-approval FDA inspection for a major peptide made by Peptisyntha for the worldwide market. Following
More informationBRUSSELS CORDENPHARMA EXPERTS TAKING CARE
CORDENPHARMA BRUSSELS EXPERTS TAKING CARE Corden Pharma Brussels S.A. 310 rue de Ransbeek 1120 Brussels Belgium Phone +32 2 263 1411 www.cordenpharma.com/contact-us/ www.cordenpharma.com Our History 1987:
More informationTotal Containment Solutions
Total Containment Solutions Buck Systems Technologies GEA Pharma Systems GEA Pharma Systems is world leader in providing advanced processing solutions for solid dosage forms to the pharmaceutical industry.
More informationCHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE
CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE Paul Stott, PhD Head of US Product Development AstraZeneca ICH Quality Guidelines Workshop BioKorea 2007 Sept 13-14
More informationSwitzerland EXPERTS TAKING CARE
CordenPharma Switzerland EXPERTS TAKING CARE CordenPharma Switzerland Eichenweg 1 4410 Liestal Switzerland Phone +41 61 906 59 59 Fax +41 61 906 59 58 sales@cordenpharma.com www.cordenpharma.com Our History
More informationContent PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2
EMA, FDA- ANDA Readiness -OSD Generics Solution Post Formulation Development Horch Guo, May. 2016, Changzhou, China Hongxing.guo@yahoo.com Content PART I: ANDA Roadmap PART II: Understanding of CPPs &
More informationNUVISAN GROUP. Our Philosophy
NUVISAN GROUP Our Philosophy 2 EARLY DEVELOPMENT Introduction to Nuvisan Fully integrated Contract Research Organisation headquarted in Neu-Ulm, southern part of Germany. Nuvisan - Early Development Headquartered
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationAlkermes Contract Pharma Services
Alkermes Contract Pharma Services Highly Potent, Poorly Soluble Product Manufacturing Contract, with 100% OTIF #501 April 2013 Fidelma Callanan Senior Director, Marketing and Commercial Development Contents
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More informationFormulation Development Services. Your trust is our reward
Formulation Development Services. Your trust is our reward Index Who we are? Mission and Vision Where we can help you? Infrastructure and Systems Site Plan Services we offer Technologies we practice Quality
More information2nd FDA/PQRI Conference on Advancing Product Quality
2nd FDA/PQRI Conference on Advancing Product Quality Generic Pharma Perspective on the Identification of Critical Quality Attributes and Critical Process Parameters Bruce D. Johnson, Ph.D. Vice President
More information7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben
7th Training School on Microencapsulation Strasbourg Februar 2015 1 Dr. Anne Ettner, Glatt Pharmaceutical Services 2 Overview 1. Introduction 2. Fluid bed equipment 3. Basics of fluid bed Wurster technology
More informationMicrocrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate
Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate Ready-to-Use High Functionality Excipient Composite Offering Advantages for Total Cost Savings Superior
More informationContinuous Manufacturing
Continuous Manufacturing Continuous ing in the Industry Continuous processing has been adopted by the majority of process industries for the manufacturing of fluids (i.e. liquids and gasses) and solids
More informationApplied Process Understanding in Drug Product Development
Applied Process Understanding in Drug Product Development A combined pharmaceutical science, materials science and chemical process engineering approach 17 October, Heidelberg, Germany ir Sander van den
More informationImplementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development. S Betterman 15Apr2015
Implementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development S Betterman 15Apr2015 Agenda Background Implementation Strategy Infrastructure Building Project Application
More informationBring your ideas to life. GEA Niro International Test Centre. engineering for a better world. GEA Process Engineering
Bring your ideas to life GEA Niro International Test Centre engineering for a better world GEA Process Engineering 2 GEA Niro Test centre The world s largest spray drying test facility In process engineering,
More informationFlexible Containment Solutions. Leigh Barratt Pfizer Rome, May 2013
Flexible Containment Solutions Leigh Barratt Pfizer Rome, May 2013 Containment Project Containment Best Practice Introduction Overview of Issues Scope of Project Improvements Made Project Summary Historical
More informationNIRS, PAT, RTR testing EU experience and regulatory perspective
NIRS, PAT, RTR testing EU experience and regulatory perspective Heidelberg, Germany October 2013 European Compliance Academy (ECA) Overview of the presentation General considerations Cases submitted in
More informationQuality by Design, Revolution or Evolution? Wim Oostra
Quality by Design, Revolution or Evolution? Wim Oostra 1993 1998 2007 2009 2013 And many more.. Content Introduction A bit of history Examples A New product Legacy product Today? The triggers The goal
More informationApplication of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013
Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for
More informationExclusive Manufacturing Solutions
Exclusive Manufacturing Solutions Helsinn Advanced Synthesis SA Making the difference with highest quality manufacturing facilities, expertise, investments and commitment 1 Index of Contents Building
More informationHigh Potency Drugs from Molecule to Market
High Potency Drugs from Molecule to Market David O Connell, Director Pharmaceutical Development, PCI Pharma Services High Potency Drugs from Molecule to Market PCI Pharma Services has invested in state-of-the-art
More informationAdvanced CIP/SIP solutions. .Premium Equipment. Processes & Equipment Solutions for Cleaning and Sterilization
Advanced CIP/SIP solutions. Advanced CIP/SIP solutions. Profile McFlusion is a highly specialized life-cycle supplier of advanced processes and equipment solutions for cleaning (CIP) and sterilization
More informationDeveloping new drug products is very expensive, especially
As appeared in March 2018 Tablets & Capsules www.tabletscapsules.com formulation Developing fixed-dose combinations Amar Patel, Bruhalkumar Shah, Deep Patel, Satish Shetty, and Anthony Qu Halo Pharmaceuticals
More informationHeadline two lines or three lines. Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing
Headline two lines or three lines Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing Contract Manufacturing Technology we re proud of We have the know-how,
More informationContract Manufacturing Services for Pre-filled Syringes
Contract Manufacturing Services for Pre-filled Syringes From Standard Solutions to Complex Products Stefan Czvitkovich, PhD Director Product Partnering Sterile Pharmaceuticals Central Europe CPhI woldwide
More informationADVANTAGES OF MULTIPARTICULATES (PELLETS):
INTRODUCTION: Multiparticulate Drug Delivery Systems (MDDS): The concept of multiple unit dosage form was initially introduced in the early 1950 s.these forms play a major role in the design of solid dosage
More informationKollicoat IR. The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms. ExcipientFest.
Kollicoat IR The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms ExcipientFest Nigel Langley Market Need Platforms Instant & Modified Release Solubilization Skin
More informationFROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities
FROM CLINICAL TO COMMERCIAL CUSTOM CAN An overview of our Development and Manufacturing capabilities THE CUSTOM DIFFERENCE Established in 1979, Custom Pharma Services has grown to become the go-to resource
More informationPAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany
PAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany ir Sander van den Ban, CEng The Unpredictability of
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationRoller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma
Roller compactors for the pharmaceutical industry BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma Roller compactors for the pharmaceutical industry Compaction and granulation in the pharmaceutical
More informationQbD implementation in Generic Industry: Overview and Case-Study
QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They
More informationGuidance for Industry
Guidance for Industry ANDAs: Blend Uniformity Analysis DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should
More informationExperts. in Solid Dosage Processing
Experts in Solid Dosage Processing developing your next process just got easier. Discover The Fluid Air Difference Our goal is to make your solid dosage process system more efficient, more innovative,
More informationIntertek Melbourn Company Presentation. MIBio 2016
Intertek Melbourn Company Presentation MIBio 2016 November 2016 Global Leader in quality solutions across all industries Innovative and bespoke quality solutions for our clients 24/7 FTSE 100 company in
More informationPartner with the Global Leader in Drug Delivery Systems
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands
More informationThe use of DMAIC Problem Solving to drive Quality Improvements
The use of DMAIC Problem Solving to drive Quality Improvements Arlene Hynes 01 May 2013 Athlone Site Overview Location Waltham Wilmington Dedicated research, development, scale-up and commercial Gainesville
More informationBEACONS. Exceeding. Expectations. Pharmaceuticals. Quality Pharmaceutical Manufacturing Services
BEACONS Pharmaceuticals Exceeding Expectations Quality Pharmaceutical Manufacturing Services BEACONS Pharmaceuticals Quality with Trust, Service with Excellence Founded in 1970, with headquarters in, Beacons
More informationYOUR MICRONISATION AND MILLING PARTNER IN THE PHARMACEUTICAL INDUSTRY
YOUR MICRONISATION AND MILLING PARTNER IN THE PHARMACEUTICAL INDUSTRY Micronised by GfM Your API Particle size (µm) We take quality personally We are a family business in the second generation. Founding
More informationHISTORY AND MILESTONES
HISTORY AND MILESTONES HISTORY AND MILESTONES DOC S.r.l., Documentation Organization & Consultancy, was established in 1997 by MASCO group C.E.O. Eng. Alberto Borella and Eng. Paolo Curtò who became Managing
More informationApplication Studies using the GTP at an Excipient Manufacturer s Laboratory
Application Studies using the GTP at an Excipient Manufacturer s Laboratory Dr. Andreas Sauer andreas.sauer@se-pfmd.com Gamlen User Meeting 22.02.2017 Outline Shin-Etsu excipients and application laboratory
More informationPharmaceutical Sciences
SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning
More informationBenefits and Opportunities of Continuous Manufacturing
Benefits and Opportunities of Continuous Manufacturing Dr. Gert Thurau MSD Manufacturing Division 1 Continuous Manufacturing is in the Spotlight Continuous processing is well controlled and the controls
More informationScientific and Regulatory challenges in Quality by Design (QbD) submissions
Health Santé Canada Canada Scientific and Regulatory challenges in Quality by Design (QbD) submissions Krishnan R. Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences TPD, Health Canada CVG, October 2007
More informationCOUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA
COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA WHO WE ARE DPT is a Contract Development and Manufacturing
More informationInt. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries
Review Article Process Validation of Tablet Dosage Form in Industries Ram Mohan S.R, N. Vishal Gupta* Pharmaceutical Quality Assurance group, Dept of Pharmaceutics, JSS University, Sri ShivarathreeshwaraNagara,
More informationReal-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology
Real-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology Authors: Piyush Patel A, Edward Godek B, Chris O Callaghan C, Dr. Ian Jones D A Colorcon, PA, USA
More informationGEA Pharma Systems. Tablet Compression - Courtoy R150 e With exchangeable turret for maximum flexibility. engineering for a better world
GEA Pharma Systems Tablet Compression - Courtoy R150 e With exchangeable turret for maximum flexibility engineering for a better world GEA Pharma Systems supplies advanced technologies for the preparation
More informationSam Halaby OSD Subject Matter Expert
OSD Subject Matter Expert Education B.S., Chemical Engineering - Clarkson University B.S., Interdisciplinary Engineering and Management - Clarkson University Professional Associations Parenteral Drug Association
More informationManagement Team. Over 35 years experience in the pharmaceuticals industry
2017 1 Overview Located in Bangalore, a Dedicated cgmp and cglp Compliance Laboratory Established in September 2010 Approved Contract research Organization by India FDA Approved by Health Canada since
More informationRoller Compaction: New trends, challenges and solutions
Roller Compaction: New trends, challenges and solutions TODD STUTZMAN, PHARM.D. R.PH. DIRECTOR, PHARMACEUTICS SARAH PYSZCZYNSKI, PH.D. PRINCIPAL SCIENTIST 21FEB2017 2017 Catalent Pharma Solutions. All
More informationSuccessful Tableting Supplement. Continuous Tableting MODUL Q A-Type Tooling. engineering for a better world
Successful Tableting Supplement Continuous Tableting MODUL Q A-Type Tooling engineering for a better world Why GEA? Operational excellence For more than a hundred years, our innovation, driven by our passion
More informationBalancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL
Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels
More informationAnushri Global Pharma Consultants
Anushri Global Pharma Consultants Your Knowledge Partner In Training, Consulting & Placement Anushri Global Pharma Consultants A Catalyst to sustainable growth Page 1 of 9 About Us Training is important
More informationProviding insight into pharmaceutical formulations
Providing insight into pharmaceutical formulations Dr Steve Ward-Smith Pharmaceutical Industry The average cost of developing a drug is reported to be approx $500 million, but up to 70% of new chemical
More informationImplementation of PAT for Real Time Release Testing. Mark Smith Process Analytical Sciences Group Pfizer, Cork
Implementation of PAT for Real Time Release Testing Mark Smith Process Analytical Sciences Group Pfizer, Cork PAT at Pfizer A key enabler for transformational strategies and new quality paradigms 9 Delivering
More informationFull-Automatic Capsule Filling Machine
Full-Automatic Capsule Filling Machine Qualicaps Co. provides domestic and foreign users with high quality hard gelatin capsules, PEG capsules, and HPMC capsules. Our high-speed fully-automatic capsule
More informationNext Generation Pharma Solutions
02/2008 For product development, clinical trials services, contract manufacturing and cold chain and logistics services partner with NextPharma Next Generation Pharma Solutions www.nextpharma.com Next
More informationThe pursuit of excipient excellence
The pursuit of excipient excellence Our roots are in dairy producing companies in both the Netherlands and New Zealand. Companies that have a history of more than 100 years. Companies that gradually transformed
More informationPHARMACEUTICAL MANUFACTURING
PHARMACEUTICAL MANUFACTURING WHAT IS PHARMACEUTICAL MANUFACTURING IT IS THE PROCESS OF INDUSTRIAL SCALE SYNTHESIS OF PHARMACEUTICAL DRUG BY PHARMACEUTICAL COMPANIES. THE PROCESS CAN BE BROKEN DOWN INTO
More informationApplication of Quality by Design (QbD) in product development. James E. Polli September 16, 2015
Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationThe Value of High-Functionality Excipients in Continuous Manufacturing Tony Carpanzano, B.S., R. Ph. Director, R&D JRS Pharma, LP, Patterson, NY
The Value of High-Functionality Excipients in Continuous Manufacturing Tony Carpanzano, B.S., R. Ph. Director, R&D JRS Pharma, LP, Patterson, NY Agenda Studies in Progress Considerations Continuous Manufacturing
More informationStage 3 - Process Validation: Measuring what matters
Stage 3 - Process Validation: Measuring what matters Trevor Schoerie - PharmOut A quote. The company that fails is the company that comes to us and says Just tell us what to do and we will do it. The company
More informationCOMPANY PROFILE. Dishman offers innovation, security of supply and value for money. Dishman Group. Research EARLY STAGE API. Preclinical.
COMPANY PROFILE Dishman is a global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and services. Dishman improves its customers businesses by providing
More informationTable of Contents. Welcome to Dishman. Our Mission. Our Focus: Client Satisfaction
Welcome to Dishman Our Mission Dishman Group continually invests in the global pharmaceutical industry, ensuring Dishman s business can provide pharmaceutical customers with high-value, high-quality products
More informationWHO DRAFT PHARMACEUTICAL DEVELOPMENT FOR MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS
23 April 2008 Quality Assurance Programme Quality Assurance and Safety: Medicines (QSM) Department of Medicines Policy and Standards (PSM) World Health Organization CH-1211 Geneva 27 Switzerland WHO DRAFT
More informationProcess & Plant Engineering + innovative Process technology. Functionalization of Granules and Pellets. Glatt. Integrated Process Solutions.
Process & Plant Engineering + innovative Process technology Functionalization of Granules and Pellets Glatt. Integrated Process Solutions. 2 Optimal processes for optimal products High-quality granules
More informationEXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS. EXPERIENCE THE BENEFITS WITH AVARA
EXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS EXPERIENCE THE BENEFITS WITH AVARA www.avara.com A GROWTH STRATEGY Avara was founded and is led by a team of industry veterans who have significant
More informationMeeting Solid Dose Formulation Challenges
Streamlining (Fast Tracking) Solid Dosage Form Development Tony Carpanzano, B.S., R. Ph. Director, Research & Development Streamlining (Fast Tracking) Solid Dosage Form Development Meeting Solid Dose Formulation
More informationPharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications
Pharma & Food Solutions ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications ETHOCEL Premium Polymers are essentially tasteless, colorless, odorless, noncaloric
More informationPolestar Power Industries (Pharma Division) Pioneer Manufacturer Of Beta-Lactum & Cephalosporin
Polestar Power Industries (Pharma Division) Pioneer Manufacturer Of Beta-Lactum & Cephalosporin R Polestar Power Industries (Pharma Division) Vill. Damuwala, Haripur Road, Barotiwala, Tehsi l Baddi, Distt.
More information3M Drug Delivery Systems. April 26, 2011
3M MDI Manufacturing April 26, 2011 3M Drug Delivery Systems Drug Delivery Systems Overview 3M Drug Delivery Systems is a division of 3M that is dedicated to the development and manufacturing of inhalation
More informationSakura Bloom Tablets P2 Mock
Sakura Bloom Tablets P2 Mock Mock P2 English version Sakura Bloom Tablets Disclaimer This mock provides an example of the contents to be included in CTD 2.3.P.2 Pharmaceutical Development section for a
More informationQuality by Design and Expertise: Accelerating time to market of complex oral solid dosage forms
CPhI Worldwide 2017 October 24 th -v 26 th, 2017 Frankfurt Quality by Design and Expertise: Accelerating time to market of complex oral solid dosage forms Lucile KOWALSKI - NPI Project Manager Guy VERGNAULT
More informationPublic Assessment Report. Scientific discussion. Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets. (lacidipine)
Public Assessment Report Scientific discussion Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets (lacidipine) NL/H/2992/001-003/DC Date: 28 July 2016 This module reflects the scientific
More informationINTRODUCTION TO INDUSTRIAL PHARMACY LAB 1
INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1 LAB INSTRUCTORS: LECT. ANAS T ARIK NAFEA ASSIST. LECT. ZAINAB HASSAN MAHDI Definition of Industrial Pharmacy The conversion of raw materials into certain dosage
More informationTHE PACMP STRATEGY. March 13-16, 2018
THE PACMP STRATEGY FDA/Xavier PharmaLink Conference 2018 March 13-16, 2018 Ajay Pazhayattil, Director- Pharmaceutical Development, AvacaPharma Inc., Vienna, VA ajay.pazhayattil@avacapharma.com PACMP ICH
More informationTotally Integrated Solutions for Pharmaceutical Industry
Totally Integrated Solutions for Pharmaceutical Industry ABOUT AUSTAR As a global leading solution provider for the pharmaceutical industry, AUSTAR provides pharmaceutical enterprises with comprehensive
More informationVetter Commercial Manufacturing
A unique blend of capabilities for aseptic fill and finish Vetter Commercial Manufacturing Delivering results across the production chain Answers that work 1 Manufacturing quality is just the beginning.
More information(12) United States Patent
(12) United States Patent Jordan USOO6495163B1 (10) Patent No.: () Date of Patent: Dec. 17, 2002 (54) MOISTURE BARRIER FILM COATING COMPOSITION, METHOD AND COATED FORM (75) Inventor: Martin Philip Jordan,
More informationMaximizing Roller Compaction Benefits with Proper Excipient Selection
A sponsored whitepaper. Maximizing Roller Compaction Benefits with Proper Excipient Selection By: Bernhard Fussnegger, Global Development and Technical Marketing, PVP/Coatings, Instant & Modified Release,
More informationExtended-release Venlafaxine Pellets: Scaling Up the Coating Process Stuart C. Porter, Bradley Beissner and Jeffrey Williamson
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-104 Page 1 of 6 Extended-release Venlafaxine Pellets: Scaling Up the Coating Process Stuart C. Porter, Bradley Beissner and Jeffrey
More informationPharmaceutical Manufacturing Technology Centre
Pharmaceutical Manufacturing Technology Centre Research themes for Initial Research Programme Call for Proposals The Centre will focus on advanced pharmaceutical manufacturing technologies with an initial
More informationFuture of Question-based Review and Regulatory Submissions
Future of Question-based Review and Regulatory Submissions Robert Iser Associate Director for Policy Development (Acting) Office of Pharmaceutical Science / CDER / FDA FDA/PQRI Conference on Evolving Product
More informationGUIDELINE FOR THE STABILITY TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)
More informationMADE WITH CARE. FDF Generics Chlorhexidine API
MADE WITH CARE FDF Generics Chlorhexidine API MEDICHEM MADE WITH CARE EXPERTISE VALUE-ADDED SOLUTIONS RELIABILITY At a Glance Meet an independently-owned developer and manufacturer of Finished Dosage Forms
More informationManual 055 Commercial Stability Testing For Formulated Products. This procedure applies to all drug products. The procedure covers:
1 Purpose Manual 055 Commercial Stability Testing For Formulated Products The intent of this procedure is to provide to manufacturing and primary packaging sites the principles of a stability program.
More informationContinuous Manufacturing. Combined approved technologies swiss made. Prospekt Nr. 655
Continuous Manufacturing Combined approved technologies swiss made Prospekt Nr. 655 Continuous Mixing and Granulation The two Swiss companies Gerteis and Gericke present the world s first solution for
More informationPage 1
Engineers to Healthcare Industry INTERTECH EQUIPTECHNOLOGIES PVT. LTD. Company Presentation 2014 www.intertechequip.com Page 1 INTERTECH Production facility Total Fabrication Area 75,000 ft2 & Clean room
More informationContinuous Processing. MODCOS for Continuous Oral Solid Dosage Production Textmasterformat in Mastervorlage eingeben
Continuous Processing MODCOS for Continuous Oral Solid Dosage Production 1 Why continuous production 2 Why Continuous Production? Saving manufacturing costs High productivity because of substantial time
More informationEMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016
EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems Jan Thomsen Warsaw, November 15 th, 2016 2 Content Emprove - An Introduction Emprove for Raw and Starting Materials
More informationFDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS
FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS 02-December-2014 San Diego, CA Kim Huynh-Ba Executive Director PHARMALYTIK Kim.huynhba@pharmalytik.com Overview Stability
More informationThe specialist contract manufacturer that your business can rely on
The specialist contract manufacturer that your business can rely on PHARMACEUTICAL MANUFACTURE MULTI-FORMAT ASSEMBLY ANALYSIS & DEVELOPMENT Surepharm provides a complete manufacturing and assembly service
More information